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PREDICTORS OF HAVING HPV VACCINATION AMONG YOUNG 
ADULTS : A BRFSS 2014 STUDY
Deborah Kanda B.Pharm; Kelly Sullivan, PhD; and Robert Vogel PhD, MA
 Data from the 2014 Behavioral Risk Factor Surveillance
System (BRFSS) were used for this study. The 8 states (AL, DE,
GA, IN, MA, MN, RI, and WY) that included the HPV
vaccination module in their survey were included in the
analyses
 There were 8,050 adults aged 18-34 years that gave valid
response when asked “Have you ever had the HPV
vaccination?”. This was categorized into “yes” and “no”
responses and used as the dependent variable
 Social factors such as age, sex, race and ethnicity, education
attainment, marital status, health insurance, PAP screening,
metropolitan status and cigarette smoking were considered
 SAS 9.4 SURVEYFREQ and SURVEYLOGISTIC regression
analyses were used to assess the relationship between HPV
vaccination status and the socio-demographic factors
 Strengths:
 The BRFSS sample size was large and allowed for a
comprehensive analysis of the data
 The study participants were from the community and
extended beyond clinical populations to achieve a true
representation of study participants
 Limitations:
 Self-reported responses
 The study only considered responses to ever had the HPV
vaccine and not on the completion rates
 Objective: To evaluate the association of social determinants
of health on HPV vaccination rates among adults between the
ages of 18-34 years
 It is imperative to improve HPV vaccination rates by focusing
on high-risk populations to prevent disparities in cervical
cancer and other cancers that are associated with HPV
infection
 HPV infection and cervical cancer disproportionately affect
minority women (9). Efforts to increase vaccination among
minority groups have the potential to reduce disparities in
HPV-related diseases and cancers
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Variable Odds ratio 95% Confidence Limits
Age in years (25-34) 0.29 (0.23, 0.36)
Race (Black vs White) 0.54 (0.40, 0.73)
Race (Other vs White) 0.57 (0.44, 0.74)
Insurance (yes) 1.71 (1.28, 2.29)
Education (>HS) 1.70 (1.36, 2.11)
Marital status (single) 2.06 (1.64, 2.59)
Metropolitan status 
(urban)
1.93 (1.23, 3.04)
Smoking status (yes) 0.87 (0.69, 1.09)
PAP test (yes) 1.67 (1.26, 2.20)
Table showing results from logistic regression analysis
Descriptive statistics of the study population, BRFSS 2014
Human Papillomavirus (HPV) is the most common sexually
transmitted infection in the United States (1) with nearly all
sexually active men and women contracting at least one form
of it in their lifetime (2). HPV can cause health problems
including genital warts and cancers such as cervical cancer,
oropharyngeal cancer and cancers of the vulva, vagina, penis
or anus (2)
According to the CDC, an estimated 79 million Americans
have HPV and about 14 million become newly infected
annually (2). About 74% of new infections occur in those aged
15-24 years (3)
Vaccination has been found to lower the risk of HPV infection
(4). The Advisory Committee on Immunization Practices
recommend routine HPV vaccination for all 11 and 12-year
olds (5). However, HPV vaccination rates lag behind compared
to other recommended vaccines for young adults (5)
 Several studies have investigated the reasons for low HPV
vaccinations and the most common cited reasons for not
vaccinating were “not recommended/needed”, “not sexually
active” and “safety concerns/side effects” (6). Other reasons
include financial concerns, low perceived risk of HPV
infection, irregular preventive care, social influences and
parental attitudes and concerns about the vaccine’s effect on
sexual behavior (7)
 There is a need to better understand social factors that are 
predictive of vaccination among young adults
 Among adults aged 18-34 years, younger age, female sex,
white race, having health insurance, higher education,
metropolitan residence, being unmarried, and having had
pap test were found to be associated with increasing odds of
receiving the HPV vaccination
 Focused educational efforts should target older adolescents,
including males and other racial groups. These efforts should
facilitate increase in HPV vaccination rates
